Koji Haratani
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology
- Immunology top 10%
- Radiology, Nuclear Medicine and Imaging top 10%
- Co-authors
- Kazuhiko NakagawaHidetoshi HayashiMasayuki TakedaKimio YonesakaKaoru TanakaYasutaka ChibaRyoji KatoHiroyasu Kaneda
- Topics
- Lung Cancer Treatments and Mutations (25 papers)Cancer Immunotherapy and Biomarkers (20 papers)Lung Cancer Research Studies (11 papers)
- Partner nations
- JapanUnited States
In The Last Decade
Koji Haratani
47 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 84
- Oncology 1.7k
- Pulmonary and Respiratory Medicine 885
- Molecular Biology 411
- Immunology 320
- Radiology, Nuclear Medicine and Imaging 227
Countries citing papers authored by Koji Haratani
This map shows the geographic impact of Koji Haratani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koji Haratani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koji Haratani more than expected).
Fields of papers citing papers by Koji Haratani
This network shows the impact of papers produced by Koji Haratani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koji Haratani. The network helps show where Koji Haratani may publish in the future.
Co-authorship network of co-authors of Koji Haratani
This figure shows the co-authorship network connecting the top 25 collaborators of Koji Haratani. A scholar is included among the top collaborators of Koji Haratani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koji Haratani. Koji Haratani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 3 | |
| 4 | 1 | |
| 5 | 9 | |
| 6 | 66 | |
| 7 | 49 | |
| 8 | 1 | |
| 9 | 5 | |
| 10 | 1 | |
| 11 | 9 | |
| 12 | 17 | |
| 13 | 172 | |
| 14 | 4 | |
| 15 | 49 | |
| 16 | 59 | |
| 17 | 24 | |
| 18 | 2 | |
| 19 | 125 | |
| 20 | 182 |
About Koji Haratani
Koji Haratani is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 48 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (25 papers), Cancer Immunotherapy and Biomarkers (20 papers) and Lung Cancer Research Studies (11 papers). The work is most often cited by research in Oncology (1.7k citations), Pulmonary and Respiratory Medicine (885 citations) and Immunology (320 citations). Koji Haratani has collaborated with scholars based in Japan and United States. Frequent co-authors include Kazuhiko Nakagawa, Hidetoshi Hayashi, Masayuki Takeda, Kimio Yonesaka, Kaoru Tanaka, Yasutaka Chiba, Ryoji Kato, Hiroyasu Kaneda, Yoshikazu Hasegawa and Keita Kudo. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The EMBO Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.